🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Excessive Sleepiness

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH NCT07625280Phase 315 sites📍 Birmingham📍 Irvine📍 Long Beach Jazz Pharmaceuticals · Tests: Xywav, Placebo Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia NCT06484348NA2 sites📍 Clermont-Ferrand📍 Lyon Hospices Civils de Lyon · Tests: Monitoring of eating behaviors, Monitoring of sleep/wake rhythm, Measure of nocturnal sleep parameters, Measure of slee… Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal NCT06872593NA1 site📍 Zurich Stefan Lakämper · Tests: CPAP-withdrawal, Test Sequence A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia NCT06752668Phase 237 sites📍 Auburn📍 Chandler📍 Scottsdale Centessa Pharmaceuticals (UK) Limited · Tests: ORX750, Placebo A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 NCT07455383Phase 344 sites📍 Cullman📍 Phoenix📍 Los Angeles Alkermes, Inc. · Tests: ALKS 2680 Dose 1, ALKS 2680 Dose 2, Placebo Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers NCT07217769NA1 site📍 Pittsburgh University of Pittsburgh · Tests: No-nap, 15-min nap, 30-min nap, 45-min nap, 60-min nap A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304) NCT07540897Phase 320 sites📍 Brandon📍 Miami📍 Winter Park Alkermes, Inc. · Tests: ALKS 2680 Dose 1, ALKS 2680 Dose 2, Placebo A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia NCT07006233NA1 site📍 Macquarie Park University of Sydney · Tests: Whole Food Ketogenic Diet, Whole Food Diet Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Low Sodium Oxybate in Patients With Idiopathic Hypersomnia NCT05837091Phase 44 sites📍 Phoenix📍 Redwood City📍 Jacksonville Mayo Clinic · Tests: Low Sodium Oxybate, 24-hour polysomnography, Nextsense EEG earbuds, Axivity device Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia NCT07646678Phase 2, Phase 324 sites📍 Chula Vista📍 Colorado Springs📍 Brandon Takeda · Tests: TAK-360, Placebo A Study Assessing Adult Patients Referred to an NHS Sleep Service With Suspected Obstructive Sleep Apnoea. This Study Aims to Compare the Sunrise Wearable Diagnostic Device Performance and Potential Inclusion in a NHS Diagnostic Pathway With Oximetry and WatchPAT Which Are Currently Used. NCT07269483NA1 site📍 Bristol Virginia Hawkins · Tests: WatchPAT 300, Oximetry, Sunrise Mainz Register of Patients With Sleep Disorders NCT05321355n/a1 site📍 Mainz Johannes Gutenberg University Mainz · Tests: Implantation of vagus nerve stimulation according to clinical indication A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions NCT05816382Phase 2, Phase 352 sites📍 Birmingham📍 Redwood City📍 Santa Ana Takeda · Tests: TAK-861 A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 NCT07502443Phase 344 sites📍 Cullman📍 Phoenix📍 Los Angeles Alkermes, Inc. · Tests: ALKS 2680 Dose 1, ALKS 2680 Dose 2, ALKS 2680 Dose 3, Placebo Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy NCT06279247n/a1 site📍 Jinan Qilu Hospital of Shandong University Digital Sleep Program for College Students with Insomnia NCT06853106NA1 site📍 Taipei Taipei Medical University · Tests: Waitlist control group, digital-based multimodal sleep management program Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) NCT06568367Phase 349 sites📍 Auburn📍 Cullman📍 Chandler Axsome Therapeutics, Inc. · Tests: Solriamfetol 150 mg, Solriamfetol 300 mg, Placebo Decreasing Nightmares in Adults With Narcolepsy NCT06383806NA1 site📍 Salt Lake City University of Utah · Tests: Imagery Rehearsal Therapy (IRT) A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy NCT07675135Phase 353 sites📍 Birmingham📍 Mobile📍 Peoria Harmony Biosciences Management, Inc. · Tests: HBS-301, Placebo Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia NCT05773872NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: Questionary Test-retest Reliability of the Maintenance of Wakefulness Test in Participants With Hypersomnolence NCT07120061NA4 sites📍 Bordeaux📍 Montpellier📍 Paris University Hospital, Bordeaux · Tests: First MWT, second MWT, actimetry A Study of TAK-360 in Adults With Idiopathic Hypersomnia NCT06812078Phase 229 sites📍 Redwood City📍 Santa Ana📍 Colorado Springs Takeda · Tests: TAK-360, Placebo A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia NCT06767683Phase 2, Phase 350 sites📍 Cullman📍 Phoenix📍 Little Rock Alkermes, Inc. · Tests: ALKS 2680, 4mg, ALKS 2680, 6mg, ALKS 2680, 8mg, ALKS 2680, 10mg, ALKS 2680, 14mg Morning Bright Light Therapy and Daytime Functioning in University Students NCT07685262NA1 site📍 Hung Hom The Hong Kong Polytechnic University · Tests: Bright light therapy (10,000 lux light box) Solriamfetol for the Treatment of Multiple Sclerosis Fatigue NCT06170970Phase 21 site📍 Baltimore Johns Hopkins University · Tests: Solriamfetol, Placebo Impact on Prognosis of Increased Sleep Quality Obtained by Personalized Night-time Nursing Care in Critically Ill Patients NCT07606495NA7 sites📍 La Roche-sur-Yon📍 La Rochelle📍 Le Mans Poitiers University Hospital · Tests: Sleepscan device, Sleep-guided nursing care The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders NCT06797284NA1 site📍 Suzhou Second Affiliated Hospital of Soochow University · Tests: Transcranial Magnetic Stimulation A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) NCT07500090Phase 342 sites📍 Birmingham📍 Peoria📍 Redwood City Harmony Biosciences Management, Inc. · Tests: HBS-301 tablet, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy